We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OM icon
3726
Outset Medical
OM
$84.8M
$16K ﹤0.01%
58
+40
+222% +$14.7K
ORC
3727
Orchid Island Capital
ORC
$1.33B
$16K ﹤0.01%
1,495
+119
+9% +$1.34K
OVBC icon
3728
Ohio Valley Banc Corp
OVBC
$210M
$16K ﹤0.01%
674
+343
+104% +$8.87K
POCI icon
3729
Precision Optics
POCI
$47.9M
$16K ﹤0.01%
+2,396
New +$15.6K
RIGL icon
3730
Rigel Pharmaceuticals
RIGL
$795M
$16K ﹤0.01%
1,218
-401
-25% -$6.37K
RKT icon
3731
Rocket Companies
RKT
$41.8B
$16K ﹤0.01%
1,762
-5,238
-75% -$45.2K
SANA icon
3732
Sana Biotechnology
SANA
$1.06B
$16K ﹤0.01%
4,815
+3,337
+226% +$13.3K
SLQT icon
3733
SelectQuote
SLQT
$129M
$16K ﹤0.01%
7,385
-6,336
-46% -$10.2K
SMRT icon
3734
SmartRent
SMRT
$286M
$16K ﹤0.01%
6,454
-1,656
-20% -$4.44K
SNFCA icon
3735
Security National Financial
SNFCA
$242M
$16K ﹤0.01%
3,196
+995
+45% +$5.66K
SPMB icon
3736
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$7.05B
$16K ﹤0.01%
739
+500
+209% +$11.1K
SSRM icon
3737
SSR Mining
SSRM
$6.56B
$16K ﹤0.01%
1,042
-17,580
-94% -$268K
TRML
3738
DELISTED
Tourmaline Bio
TRML
$16K ﹤0.01%
867
-36
-4% -$594
UBT icon
3739
ProShares Ultra 20+ Year Treasury
UBT
$57.4M
$16K ﹤0.01%
+606
New +$16K
UFI icon
3740
UNIFI
UFI
$120M
$16K ﹤0.01%
1,968
-3,073
-61% -$27.4K
URGN icon
3741
UroGen Pharma
URGN
$2.35B
$16K ﹤0.01%
1,778
+37
+2% +$340
XXII
3742
22nd Century Group
XXII
$1.49M
– –
0
– –
TBRG
3743
DELISTED
TruBridge
TBRG
$16K ﹤0.01%
529
-1,465
-73% -$42.7K
ASBP
3744
Aspire Biopharma
ASBP
$10.2M
$16K ﹤0.01%
+1
New +$12.5K
ME
3745
DELISTED
23andMe Holding Co
ME
$16K ﹤0.01%
342
+133
+64% +$6.42K
CHUY
3746
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$16K ﹤0.01%
433
-505
-54% -$17.2K
SNPO
3747
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$16K ﹤0.01%
1,742
-16,897
-91% -$167K
SCRM
3748
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$16K ﹤0.01%
+1,578
New +$15.9K
KAMN
3749
DELISTED
Kaman Corp
KAMN
$16K ﹤0.01%
716
-3,337
-82% -$79.4K
CBAY
3750
DELISTED
Cymabay Therapeutics
CBAY
$16K ﹤0.01%
1,828
-229
-11% -$1.83K
148 149
150
151 152

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.